biontech se news - Search News

BioNTech to pay $1.2 billion over vaccine royalties

BioNTech to pay Covid-19 vaccine settlements in US

The German pharmaceutical company BioNTech announced on Friday that it has reached settlements in the US to resolve a royalties dispute with the US National Institutes of Health (

Business Insider · 1d

BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties

Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is trading at $114.25, up 0.42 percent on the Nasdaq.

YAHOO!Finance · 20h

BioNTech Settles Royalty Dispute with University of Pennsylvania

BioNTech SE has reached a settlement agreement with the University of Pennsylvania over a royalty dispute related to its COVID-19 vaccine, developed in collaboration with Pfizer. The agreement involves a payment of up to $467 million to Penn,

Seeking Alpha on MSN · 1d

BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claims

BioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine royalty claims. Read more here.

BioNTech SE ADR rises Friday, outperforms market

BioNTech SE ADR closed $17.54 below its 52-week high ($131.49), which the company achieved on September 17th.

20h

BioNTech Settles Royalty Dispute with NIH for $791.5 Million

BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a dispute with the National Institutes of Health (NIH) regarding royalties allegedly owed on sales of its COVID-19 vaccine, ...

Brokerages Set BioNTech SE (NASDAQ:BNTX) Price Target at $140.76

BioNTech SE (NASDAQ:BNTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen ...

BioNTech SE ADR falls Thursday, underperforms market

The ADR's fall snapped a three-day winning streak.

Daily4h

BioNTech enters settlement with US National Institutes of Health, University of Pennsylvania

Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National ...

ETF Daily News5d

BioNTech SE (NASDAQ:BNTX) Shares Sold by Tidal Investments LLC

Tidal Investments LLC lessened its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 39.5% in the third quarter, ...

The Motley Fool4d

BioNTech Se (NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs ...

Morningstar2d

BioNTech SE ADR BNTX

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNTech SE (BNTX – Research Report), Vertex Pharmaceuticals ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results